Abstract:Mesoporous silica nanoparticles (MSNs) are promising solid supports for controlled anticancer drug delivery. Herein, we report biocompatible layer-by-layer (LbL) coated MSNs (LbL-MSNs) that are designed and crafted to release encapsulated anticancer drugs, e.g., doxorubicin hydrochloride (DOX), by changing the pH or by adding competitive agents. The LbL coating process comprises bis-aminated poly(glycerol methacrylate)s (BA-PGOHMAs) and cucurbit[7]uril (CB[7]), where CB[7] serves as a molecular bridge holding two different bis-aminated polymeric layers together by means of host-guest interactions. This integrated nanosystem is tuned to respond under specific acidic conditions or by adding adamantaneamine hydrochloride (AH), attributed to the competitive binding of hydronium ions or AH to CB[7] with BA-PGOHMAs. These LbL-MSN hybrids possess excellent biostability, negligible premature drug leakage at pH 7.4, and exceptional stimuli-responsive drug release performance. The pore sizes of the MSNs and bis-aminated compounds (different carbon numbers) of BA-PGOHMAs have been optimized to provide effective integrated nanosystems for the loading and release of DOX. Significantly, the operating pH for the controlled release of DOX matches the acidifying endosomal compartments of HeLa cancer cells, suggesting that these hybrid nanosystems are good candidates for autonomous anticancer drug nanocarriers actuated by intracellular pH changes without any invasive external stimuli. The successful cellular uptake and release of cargo, e.g., propidium iodide (PI), in human breast cancer cell line MDA-231 from PI-loaded LbL-MSNs have been confirmed by confocal laser scanning microscopy (CLSM), while the cytotoxicities of DOX-loaded LbL-MSNs have been quantified by the Cell Counting Kit-8 (CCK-8) viability assay against HeLa cell lines and fibroblast L929 cell lines. The uptake of DOX-loaded LbL-MSNs by macrophages can be efficiently reduced by adding biocompatible hydrophilic poly(ethylene glycol) or CB[7] without destroying the capping. In vivo tumor-growth inhibition experiments with BALB/c nude mice demonstrated a highly efficient tumor-growth inhibition rate of DOX-loaded LbL-MSNs, suggesting that the novel type of LbL-MSN materials hold great potentials in anticancer drug delivery.

Ph-Sensitive Mesoporous Silica Nanoparticles Anticancer Prodrugs for Sustained Release of Ursolic Acid and the Enhanced Anti-Cancer Efficacy for Hepatocellular Carcinoma Cancer

A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways.

Acid-responsive intracellular doxorubicin release from click chemistry functionalized mesoporous silica nanoparticles

Simultaneous Inhibition of Growth and Metastasis of Hepatocellular Carcinoma by Co-Delivery of Ursolic Acid and Sorafenib Using Lactobionic Acid Modified and Ph-Sensitive Chitosan-Conjugated Mesoporous Silica Nanocomplex

Polymeric micelles loading with ursolic acid enhancing anti-tumor effect on hepatocellular carcinoma

A self-assembly nanodrug delivery system based on amphiphilic low generations of PAMAM dendrimers-ursolic acid conjugate modified by lactobionic acid for HCC targeting therapy

A Ph-Responsive Dissociable Mesoporous Silica-Based Nanoplatform Enabling Efficient Dual-Drug Co-Delivery and Rapid Clearance for Cancer Therapy

Enhanced anti-tumor activity of a drug through pH-triggered release and dual targeting by calcium phosphate-covered mesoporous silica vehicles

Mesoporous Silica Nanoparticles Coated by Layer-by-Layer Self-assembly Using Cucurbit[7]uril for in Vitro and in Vivo Anticancer Drug Release.

Super-pH-Sensitive Mesoporous Silica Nanoparticle-Based Drug Delivery System for Effective Combination Cancer Therapy

Acid Susceptible Ultrathin Mesoporous Silica Coated On Layered Double Hydroxide Nanoplates For Ph Responsive Cancer Therapy

Mesoporous Silicon Nanoparticles with Liver-Targeting and pH-Response-Release Function Are Used for Targeted Drug Delivery in Liver Cancer Treatment

Synergistic Anti-Tumor Effect of Dual Drug Co-Assembled Nanoparticles Based on Ursolic Acid and Sorafenib

Amino-functionalized mesoporous silica nanoparticles as efficient carriers for anticancer drug delivery.

Lactobionic Acid-Functionalized Hollow Mesoporous Silica Nanoparticles for Cancer Chemotherapy and Phototherapy

Ultra-small Mesoporous Silica Nanoparticles As Efficient Carriers for Ph Responsive Releases of Anti-Cancer Drugs

Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells

Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.

Cloaking Mesoporous Silica Nanoparticles with Phenylboronic Acid-Conjugated Human Serum Albumin-Co-polydopamine Films for Targeted Drug Delivery

A Ph-Responsive Mesoporous Silica Nanoparticle-Based Drug Delivery System for Targeted Breast Cancer Therapy

Hollow Mesoporous Silica Nanoparticles Facilitated Drug Delivery Via Cascade Ph Stimuli in Tumor Microenvironment for Tumor Therapy.